Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at cisplatin, gemcitabine and sunitinib for advanced transitional cell cancer of the urinary system (SUCCINCT)

Overview

Cancer types:

Bladder cancer, Kidney cancer, Transitional cell cancer

Status:

Results

Phase:

Phase 2

Details

This trial looked at a drug called sunitinib alongside chemotherapy for transitional cell cancer. It was for people whose cancer had grown into surrounding tissue (is ) or had spread to another part of their body. The trial was supported by Cancer Research UK.

Transitional cells (also called urothelial cells) are a part of the urinary system. The urinary system filters waste products from the blood and makes urine. Transitional cells line the centre of each kidney (renal pelvis), the bladder and the tubes that drain urine from the kidneys to the bladder (ureters). So you can get transitional cell cancer in the kidney, bladder or ureters.

Recruitment start: 20 July 2009

Recruitment end: 1 February 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Thomas Geldart

Supported by

Cancer Research UK

Cardiff University

Experimental Cancer Medicine Centre (ECMC)

NIHR Clinical Research Network: Cancer

Pfizer

Wales Cancer Trials Unit

Other information

This is Cancer Research UK trial number CRUK/07/044.

Last reviewed: 16 September 2015

CRUK internal database number: 4009

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.